Steve Carroll
About Steve Carroll
Steve Carroll serves as the Vice President of Preclinical Sciences at IGM Biosciences, where he has worked since 2015. He possesses extensive experience in biotechnology, particularly in the development of biologics and therapeutic programs.
Work at IGM Biosciences
Steve Carroll has served as Vice President of Preclinical Sciences at IGM Biosciences since 2015. In this role, he oversees the preclinical development of therapeutic programs, focusing on biologics. His responsibilities include creating comprehensive product development plans that encompass timelines, budgets, and Gantt charts. Carroll's expertise in developing product profiles and specifications for biologics is integral to the company's mission. He has participated in numerous therapeutic programs involving various recombinant antibodies and proteins, contributing to the advancement of innovative treatments.
Previous Experience at XOMA (US) LLC
Before joining IGM Biosciences, Steve Carroll held multiple positions at XOMA (US) LLC. He served as Vice President of Preclinical Research from 1987 to 2002, where he gained extensive experience in the field of biotechnology. He later took on the role of Vice President of Scientific and Product Development from 2002 to 2003. During his tenure at XOMA, Carroll was involved in various projects that enhanced his skills in product development and regulatory submissions.
Education and Expertise
Steve Carroll earned a Ph.D. in Microbiology from UCLA, where he studied from 1974 to 1979. He also holds a Bachelor of Arts in Biology from UC San Diego, which he completed in 1974. His educational background provides a strong foundation for his expertise in developing product profiles for biologics and evaluating the feasibility of biotechnology projects. Carroll's academic training supports his ability to draft sections for Investigational New Drug (IND) applications and Biologics License Applications (BLAs).
Skills in Product Development and Regulatory Affairs
Steve Carroll possesses a diverse skill set in product development and regulatory affairs. He is experienced in drafting non-clinical and Chemistry, Manufacturing, and Controls (CMC) regulatory document sections. His ability to establish and manage both internal and external in vitro and in vivo assays is critical for advancing research concepts into development leads. Carroll is skilled in identifying essential experiments necessary for project advancement, which is vital for the success of biotechnology initiatives.
Collaborative Interaction with Stakeholders
In his professional roles, Steve Carroll has demonstrated effective interaction with scientists, management, and board members. His collaborative approach facilitates product development and enhances communication across various teams. By engaging with stakeholders, Carroll ensures that project goals align with organizational objectives, contributing to the overall success of therapeutic programs at IGM Biosciences and his previous positions.